Measuring of quality life for patients with locally recurrent rectal cancer
A new study produces the first disease-specific, psychometrically robust and validated measure of quality life for patients with locally recurrent rectal cancer.
'A smarter kinder approach to treatment’ for anal cancer
Reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects, recent clinical trial results have shown.
FMH and University Partnership Award Winners 2023
We are delighted to announce the winners of the 2023 Faculty of Medicine and Health and University Partnership Awards.
Mid Yorkshire Trust secures ambition of teaching status, a boost to recruitment and innovation opportunities
The Mid Yorkshire Hospitals NHS Trust this week announced it is officially a Teaching Trust, and will now be called Mid Yorkshire Teaching NHS Trust.
Novel target could be important for multiple myeloma therapy development
Scientists have identified a molecule on the tumour cells of Multiple Myeloma that could be a target for developing new treatment therapies.